J. Scarpello

发表

Response to: Angiotensin receptor blockers in hypertension: the emerging role in diabetes mellitus

G. Varughese, J. Scarpello, 2006, International journal of clinical practice.

Intestinal glucose and amino acid absorption in healthy volunteers and noninsulin-dependent diabetic subjects.

M. Gulliford, G. G. Pover, J. Scarpello, 1989, The American journal of clinical nutrition.

Evidence for the involvement of cGMP and protein kinase G in nitric oxide‐induced apoptosis in the pancreatic B‐cell line, HIT‐T15

N. Morgan, G. Williams, G.T. Williams, 1997, FEBS letters.

Figure 1. Role of metformin and H2RA/PPI in the evolution of B12 deficiency.

S. Croxson, G. Varughese, J. Scarpello, 2006 .

Metformin, heart failure, and lactic acidosis: is metformin absolutely contraindicated?

A. Tahrani, F. Hanna, G. Varughese, 2007, BMJ : British Medical Journal.

An assessment of the coverage of a district‐wide diabetic retinopathy screening service

H. Buch, J. Scarpello, G. Varughese, 2005, Diabetic medicine : a journal of the British Diabetic Association.

NICE guidelines and diabetic retinopathy

J. Scarpello, 2002 .

The long and short of metformin-related vitamin B12 deficiency.

A. Tahrani, G. Varughese, J. Scarpello, 2007, Archives of internal medicine.

Effect of metformin on bile salt circulation and intestinal motility in Type 2 diabetes mellitus

H. Howlett, H. Howlett, J. Scarpello, 1998, Diabetic medicine : a journal of the British Diabetic Association.

Effects of tyrosine kinase inhibitors on cell death induced by sodium fluoride and pertussis toxin in the pancreatic β‐cell line, RINm5F

N. Morgan, J. Scarpello, J. Elliott, 2001 .

Differential effect of protein and fat ingestion on blood glucose responses to high- and low-glycemic-index carbohydrates in noninsulin-dependent diabetic subjects.

M. Gulliford, M. Gulliford, J. Scarpello, 1989, The American journal of clinical nutrition.

The mechanism of action of guar gum in improving glucose tolerance in man.

N. A. Blackburn, N. Read, A. Holgate, 1984, Clinical science.

Expression and functional activity of PPAR c in pancreatic b cells 1

N. Morgan, Stephen A. Smith, S. McBain, 2004 .

Differential effects of genistein on apoptosis induced by fluoride and pertussis toxin in human and rat pancreatic islets and RINm5F cells.

N. Morgan, J. Scarpello, J. Elliott, 2002, The Journal of endocrinology.

Human islets of Langerhans express Fas ligand and undergo apoptosis in response to interleukin-1beta and Fas ligation.

N. Morgan, G. Williams, R. James, 1998, Diabetes.

Correlation between pancreatic enzyme secretion and plasma concentration of human pancreatic polypeptide in health and in chronic pancreatitis.

A. Vinik, C. Owyang, J. Scarpello, 1982, Gastroenterology.

Selective stimulation of glucagon secretion by β2‐adrenoceptors in isolated islets of Langerhans of the rat

N. Morgan, N. Berrow, J. Scarpello, 1991, British journal of pharmacology.

Evidence that protein kinase Cdelta is not required for palmitate-induced cytotoxicity in BRIN-BD11 beta-cells.

N. Morgan, M. Tadayyon, S. Smith, 2004, Journal of molecular endocrinology.

A specific inhibitor of cytosolic phospholipase A2 activity, AACOCF3, inhibits glucose-induced insulin secretion from isolated rat islets.

N. Morgan, J. Scarpello, A. C. Loweth, 1996, Biochemical and biophysical research communications.

Heterotrimeric G-proteins are implicated in the regulation of apoptosis in pancreatic beta-cells.

N. Morgan, G. Williams, J. Scarpello, 1996, Experimental cell research.

Impaired glucose tolerance and the risk of ischaemic stroke: another focus.

A. Tahrani, G. Varughese, J. Scarpello, 2007, Age and ageing.

Phospholipase A2 expression in human and rodent insulin-secreting cells

N. Morgan, J. Scarpello, A. C. Loweth, 1995, Molecular and Cellular Endocrinology.

Evidence that protein kinase C (cid:1) is not required for palmitate-induced cytotoxicity in BRIN-BD11 (cid:2) -cells

N. Morgan, M. Tadayyon, S. Smith, 2004 .

Dissociation between Fas expression and induction of apoptosis in human islets of Langerhans

N. Morgan, G. Williams, S. McBain, 2000, Diabetes, obesity & metabolism.

Diabetic dyslipidaemia: the role of niacin derivatives lack long‐term outcome data

G. Varughese, J. Scarpello, 2006 .

Evidence that the presence of arginine can lead to overestimation of glucagon levels measured by radioimmunoassay.

N. Morgan, J. Scarpello, R. J. Lacey, 1992, Clinica chimica acta; international journal of clinical chemistry.

Metformin and the intestine

C. Bailey, C. J. Bailey, C. Wilcock, 2008, Diabetologia.

Metformin therapy and clinical uses

H. Howlett, J. Scarpello, 2008, Diabetes & vascular disease research.

United Kingdom Prospective Diabetes Study 24: A 6-Year, Randomized, Controlled Trial Comparing Sulfonylurea, Insulin, and Metformin Therapy in Patients with Newly Diagnosed Type 2 Diabetes That Could Not Be Controlled with Diet Therapy

R. J. Hayes, R. Holman, C. Fox, 1998, Annals of Internal Medicine.

A Treatable Cause of Recurrent Severe Hypoglycemia

M. Burge, K. Hardy, P. Boyle, 1994, Diabetes Care.

Treating dyslipidaemia in the setting of diabetes mellitus and cardiovascular disease: a less commonly perceived therapeutic perspective in clinical practice

J. Scarpello, G. Varughese, 2006, International journal of clinical practice.

Non-traumatic rhabdomyolysis: the emerging role of CYP 3A4 in diabetes mellitus.

G. Varughese, J. Scarpello, 2006, Journal of the Royal Society of Medicine.

Concentration-dependent effects of adrenaline on the profile of insulin secretion from isolated human islets of Langerhans.

N. Morgan, R. James, N. London, 1993, The Journal of endocrinology.

Differential effects of β-adrenergic agonists on insulin secretion from pancreatic islets isolated from rat and man

N. Morgan, N. Berrow, R. James, 1990 .

Improving survival with metformin: the evidence base today.

J. Scarpello, 2003, Diabetes & metabolism.

Acute renal failure and disseminated intravascular coagulation following diabetic ketoacidosis

J. Scarpello, 2007, Acta diabetologia latina.

Review: Optimal dosing strategies for maximising the clinical response to metformin in type 2 diabetes:

J. Scarpello, 2001 .

Expression and functional activity of PPARγ in pancreatic β cells

N. Morgan, Stephen A. Smith, S. McBain, 2004, British journal of pharmacology.

Metformin and vitamin B12 deficiency: the role of H2 receptor antagonists and proton pump inhibitors.

G. Varughese, J. Scarpello, 2007, Age and ageing.

Mono‐unsaturated fatty acids protect against β‐cell apoptosis induced by saturated fatty acids, serum withdrawal or cytokine exposure

N. Morgan, Stephen A. Smith, M. Tadayyon, 2004, FEBS letters.

Correlation between duodenal trypsin and plasma pancreatic polypeptide: Evidence for modulation of human pancreatic polypeptide (hPP) responses to secretin by duodenal luminal factor(s)

A. Vinik, C. Owyang, J. Scarpello, 1980 .

Expression of alpha 2- and beta-adrenoceptor subtypes in human islets of Langerhans.

N. Morgan, R. James, C. Perrett, 1996, The Journal of endocrinology.

Comparison of lipid-lowering effects of low-dose fluvastatin and conventional-dose gemfibrozil in patients with primary hypercholesterolemia.

G. Jackson, G. Mcinnes, M. Mir, 1994, The American journal of medicine.